WHO ICTRP trial
The effect of combination therapy with Alendronate and Eldecalcitol for…
JPRN-UMIN000009588 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000009588 |
|---|---|
| Public title | The effect of combination therapy with Alendronate and Eldecalcitol for glucocorticoid induced osteoporosis -switch from Alfacalcidol to Eldecalcitol- |
| Scientific title | The effect of combination therapy with Alendronate and Eldecalcitol for glucocorticoid induced osteoporosis -switch from Alfacalcidol to Eldecalcitol- - The effect of combination therapy with Alendronate and Eldecalcitol for glucocorticoid induced osteoporosis -switch from Alfacalcidol to… |
| Primary sponsor | Department of Rheumatic Disease, Shinko Hospital |
| Secondary sponsors | Shimane University Faculty of Medicine DS Pharma Biomedical Co,Ltd. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | glucocorticoid induced osteoporosis |
| Interventions | Alendronate(35mg/week)+ Alfacalcidol(1.0mcg/day) Alendronate (35mg/week) + Eldecalcitol (0.75mcg/day) |
| Registration date | Dec 20, 2012 |
| Target size | 60 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: